Navigation Links
Stereotactic Breast Biopsy introduced with Fischer-Giotto Image at American Society of Breast Surgeons course

CHICAGO, IL (PRWEB) May 01, 2013

Fischer Medical Technologies will work with the educational arm of the American Society of Breast Surgeons (ASBS) by providing the use of the Fischer-Giotto Image for the introductory stereotactic breast biopsy workshop at the upcoming 14th annual ASBS conference. Fischer’s skilled technical staff from the U.S. and Italy will be assisting with the instruction.

The Fischer-Giotto Image is the only prone breast imaging system that uses the same detector during both the mammography exam and the biopsy procedure. This unique feature minimizes the need for additional exposures and dose, while providing superior quality images. The precise correlation of images produced by the dual-use detector provides more confidence, especially in vacuum assisted biopsies of subtle micro-calcifications.

The Fischer-Giotto Image, a FFDM (full-field digital mammography) and stereotactic breast biopsy system, was introduced in the U.S. in 2012. The first installation of the Fischer-Giotto Image was at Boulder Community Hospital, in Boulder, CO, replacing the Fischer Mammotest system. It is receiving enthusiastic reviews from both the physicians and technologists. Additional systems have been installed at Mankato Clinic (MN), Saratoga Hospital (NY) and Derby Family MedCenters (KS).

ASBS’s Stereotactic Breast Biopsy: An Introductory Course is a full-day session geared toward the breast surgeon with little or no prior experience in stereotactic breast biopsy. The course is currently filled to capacity, however, the Fischer-Giotto Image can be seen at the Fischer-Giotto Booth #203, at the ASBS conference, May 1-5, at the Sheraton Chicago Hotel & Towers.

Fischer’s roots go back to 1910, when H.G. Fischer, the oldest manufacturer of X-ray imaging devices in the United States, began its operations in Chicago, IL. Fischer Medical Technologies LLC is based in Broomfield, Colorado and is the successor company to Fischer Imaging. Fischer Medical was formed in 2006 by the original founders of Fischer Imaging following the acquisition of all the assets of Fischer Imaging, including all patents, trademarks, product designs, and 510(k) filings. Fischer’s focus is on developing differentiated technologies to improve imaging systems’ efficiency and effectiveness through innovative and creative designs. Contact

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Robert Lowen MD, Expert Bay Area Plastic Surgeon, Announces Cutting-Edge 3-D Crisalix Imaging Technology to Aid Patients in Choosing their Breast Implant Size
2. Patti Flint MD, A Top Female Plastic Surgeon in the Southwest, Is Proud To Offer Cutting-Edge 3D Crisalix Technology to Patients When Selecting Breast Implants
3. Dr. Vasquez at the Connecticut Plastic Surgery Group Now Offers the Unique Crisalix 3D Simulations for Facial Aesthetics and Breast Augmentation
4. QVC and Fashion Footwear Association of New York Invest in Personalized Breast Cancer Therapy Research
5. The First Dedicated Breast Cancer Cell Line Transfection Reagent
6. NewLink Genetics Initiates Phase 2 Trial of IDO Pathway Inhibitor, Indoximod, for the Treatment of Metastatic Breast Cancer
7. University of Maryland Breast Cancer Research Pioneer Dr. Angela Brodie Appointed Fellow of New American Association for Cancer Research Academy
8. Genedata Enables Research to Improve Personalized Treatment of Breast and Ovarian Cancer
9. Positive Clinical Breast Cancer Data Presented for NuView’s Molecular Imaging Biomarker NLS-VPAC1
10. Frost & Sullivan: Modest Growth Projected in the U.S. Breast Imaging Systems Market Amidst Increasing Breast Cancer Prevalence
11. Transition in cell type parallels treatment response, disease progression in breast cancer
Post Your Comments:
(Date:10/11/2017)... Tampa Bay, Florida (PRWEB) , ... October 11, ... ... Food and Drug Administration (FDA) has granted orphan drug designation to SBT-100, its ... antibody (sdAb) for the treatment of osteosarcoma. SBT-100 is able to cross the ...
(Date:10/10/2017)... CA (PRWEB) , ... October ... ... a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today ... of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration ...
(Date:10/10/2017)... ... ... Dr. Bob Harman, founder and CEO of VetStem Biopharma, Inc. ... event entitled “Stem Cells and Their Regenerative Powers,” was held on August 31st, ... was joined by two human doctors: Peter B. Hanson, M.D., Chief of Orthopedic Surgery, ...
(Date:10/10/2017)... SANTA CRUZ, Calif. , Oct. 10, 2017 /PRNewswire/ ... SBIR grant from the NIH to develop RealSeq®-SC (Single ... preparation kit for profiling small RNAs (including microRNAs) from ... Cell Analysis Program highlights the need to accelerate development ... "New techniques for ...
Breaking Biology Technology:
(Date:4/5/2017)... , April 5, 2017 Today HYPR ... that the server component of the HYPR platform is ... providing the end-to-end security architecture that empowers biometric authentication ... HYPR has already secured over 15 million users across ... manufacturers of connected home product suites and physical access ...
(Date:3/30/2017)... ANGELES , March 30, 2017  On April ... Hack the Genome hackathon at Microsoft,s ... exciting two-day competition will focus on developing health and ... Hack the Genome is the ... been tremendous. The world,s largest companies in the genomics, ...
(Date:3/28/2017)... PUNE, India , March 28, 2017 ... (Analog, IP, Biometrics), Hardware (Camera, Monitors, Servers, Storage Devices), ... Maintenance), Vertical, and Region - Global Forecast to 2022", ... 30.37 Billion in 2016 and is projected to reach ... 15.4% between 2017 and 2022. The base year considered ...
Breaking Biology News(10 mins):